NCT05289505

Brief Summary

This is a prospective study with a historical comparator. Each of the prospective study endpoints will be compared to data collected retrospectively in patients treated with radiation therapy prior to the implementation of the MUSIC-CARE device.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
83

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 18, 2022

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

January 25, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 21, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 26, 2023

Completed
Last Updated

April 4, 2024

Status Verified

September 1, 2022

Enrollment Period

8 months

First QC Date

January 25, 2022

Last Update Submit

April 3, 2024

Conditions

Keywords

Anxiety

Outcome Measures

Primary Outcomes (1)

  • The main objective of the study is to evaluate the impact of the MUSIC-CARE device on the level of anxiety perceived by patients during radiotherapy.

    Perceived anxiety will be measured by the anxiety score (total A), assessed with the Hospital Anxiety and Depression Scale (HADS). To screen for anxiety symptomatology, the following interpretation is: Total A score at 7 or less: no symptomatology, Total A score of 8 to 10: questionable symptomatology, and Total A score equal to 11 and above: definite symptomatology. Anxiety will be assessed at the medical consultation, after 5 sessions and at the end of the treatment. The patients' score after 5 sessions will be used as the primary endpoint to evaluate the impact of the to evaluate the impact of the device.

    The analysis will take place after the last visit (usual 6-month visit) of the last included patient, i.e. 6 months after the end of treatment of the last patient, and within a maximum of one year after this visit.

Study Arms (1)

Prospective phase

This prospective phase involves all patients with an initial HADS score \> 7 and initiating treatment in the radiotherapy department. The treatment sessions will be performed with music, using the MUSIC-CARE device. In the event of technical problems, unavailability of equipment, or the patient's wishes, some radiotherapy sessions may be conducted without music. Nevertheless, a minimum of one weekly session with music is required for the analysis of the study.

Device: MUSIC-CARE

Interventions

This device allows the listening of music using different sequences of instrumental music created specifically, and using principles based on hypno-analgesia, that is to say the association of hypnotic techniques and approaches to help or analgesic, medicated or not. It consists of a tablet application containing instrumental music pieces, specially created and recorded for Music-Care. Each piece is at least 20 minutes long. The music can be played through headphones or speakers.

Prospective phase

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients, all cancers combined, with an initial HADS score \> 7 and initiating treatment in the radiotherapy department are concerned by this study.

You may qualify if:

  • Patients over 18 years of age
  • Patients undergoing radiotherapy for curative treatment
  • Patients with at least 15 sessions of radiotherapy
  • Patients with an anxiety score \> 7 on the total A of the HADS scale at the time of medical consultation

You may not qualify if:

  • Minor patients
  • Pregnant or breastfeeding patients
  • Patients with major hearing loss
  • Patients with psychotic disorders
  • Patients who do not understand or read the French language
  • Patients under guardianship or deprived of liberty
  • Patients requiring radiotherapy with respiratory servo-control (the MUSIC-CARE cannot be used due to technical constraints)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre de Lutte contre le Cancer Eugène Marquis

Rennes, Brittany Region, 35042, France

Location

MeSH Terms

Conditions

Radiation InjuriesAnxiety Disorders

Condition Hierarchy (Ancestors)

Wounds and InjuriesMental Disorders

Study Officials

  • Coralie Hulot

    Centre de Lutte contre le Cancer Eugène Marquis

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 25, 2022

First Posted

March 21, 2022

Study Start

January 18, 2022

Primary Completion

August 31, 2022

Study Completion

March 26, 2023

Last Updated

April 4, 2024

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations